| Position | Action |
|---|---|
| Existing overweight exposure | Trim ~30% of position |
| Final position size | Cap at 2-3% of portfolio |
| Trim proceeds | Hold 15-20% in cash at ~4%+ yield rather than redeploying |
| Break below $141.00 on volume | Warrant further reduction toward $135.13 |
PG is a generational compounding machine with structural competitive advantages (65+ billion-dollar brands, 30.29% ROE, 330bps margin expansion) that make current weakness near technical support a rare asymmetric entry opportunity for long-term investors.
| Indicator | Value | Signal |
|---|---|---|
| Close | 144.97 | bearish |
| Open | 145.85 | — |
| High | 147.15 | — |
| Low | 144.26 | — |
| Volume | 6,559,286 | — |
| 10 EMA | 146.19 | bearish |
| 50 SMA | 146.44 | neutral |
| 200 SMA | 145.86 | neutral |
| MACD | -0.42 | bearish |
| MACD Signal | 0.02 | bearish |
| MACD Histogram | -0.44 | bearish |
| RSI(14) | 45.58 | bearish |
| Bollinger Upper Band | 151.04 | — |
| Bollinger Middle Band | 147.12 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain Underweight with tighter, tranched execution; trim ~30% of overweight PG exposure in thirds
Tactical Underweight on deteriorating operational trajectory, not structural Sell. Long-term quality thesis (Dividend King, 30% ROE, 1.0x net debt/EBITDA, fortress balance sheet) remains intact; underweighting on timing, capital allocation discipline, and multiple compression, not on business model. October Q1 FY27 catalyst is validation point—if PG demonstrates volume growth AND margin defense simultaneously, Underweight rotates toward Hold; if PG misses lowered guide or shows capital stress signals, Underweight deepens toward Sell.
When: Current $144-145 levels
Then: Trim 1/3 of position
↩ rebuts: “$1B cost hit and FY27 guidance below consensus signals structural damage”
· concedes: The bear's case focuses on near-term 1-3 month catalysts while the bull case is a 10-year compounding thesis; The recent 4.3% pullback from $151.62 represents a normal, healthy correction within an uptrend; The $141 support level is the hard stop where bulls must defend position
PG is a fully-priced-to-richly-priced defensive in a hostile macro environment with deteriorating fundamentals — not a compounding fortress, but a debt-funded yield maintenance trap at risk of further multiple compression and downside to $130-$138.
→ vs conservative: HSBC abandoning their own Buy rating with an 18% price target slash is direct evidence the 'quality always wins' thesis has failed institutionally - same flawed logic that caused 27% losses for Apple investors in 2022
→ vs conservative: DCF showing undervaluation while Simply Wall St shows 'pricey on earnings' is classic value trap territory - the multiple hasn't de-rated enough to reflect the growth reset, not evidence of safety
→ vs conservative: Dividend being funded by debt at 3% yield while borrowing costs rise is not 'normal for blue chips' - it's a dividend cut candidate the moment credit markets tighten
→ vs neutral: The 200 SMA at $145.86 is about to break given three independent momentum indicators all aligned bearish - waiting for 'confirmation' means buying through another leg down to $140 or lower
→ vs neutral: Waiting for 50 SMA reclaim or flush to support is reactive rather than proactive - by the time confirmation arrives, you're holding through the drawdown rather than positioning ahead of it
→ vs neutral: Any bounce would only retest $147-148 resistance before the next leg down - the risk-reward of holding through that round trip is massively asymmetric to the downside
| Bollinger Lower Band | 143.21 | bullish |
| ATR(14) | 3.55 | — |
| VWMA(20) | 146.83 | bearish |
Support: 143.21 · 141 · 141.5 · 140 | Resistance: 145.86 · 147.12 · 148.88 · 151.04 · 151.62
PG is in a short-term corrective phase within a longer-term uptrend, trading below all three key moving averages. The MACD issued a fresh bearish crossover with expanding negative histogram, confirming active downside momentum, while RSI at 45.58 remains neutral. The 200 SMA at $145.86 is the critical near-term pivot level, with the lower Bollinger Band at $143.21 serving as the next major support. The overall technical picture suggests a cautiously neutral bias near-term with a constructive medium-term view contingent on key support holding. ATR of $3.55 indicates modestly elevated volatility, useful for position sizing and stop-loss placement.
Market Cap
$337.58B
PE Ratio (TTM)
21.90
Forward PE
19.56
PEG Ratio
5.57
Price to Book
6.35
Beta
0.377
Dividend Yield
3.01%
Revenue (TTM)
$87.03B
Net Income (TTM)
$16.05B
Diluted EPS (TTM)
$6.62
Forward EPS
$7.41
Gross Margin
50.7%
Operating Margin (TTM)
19.53%
Net Profit Margin
18.44%
EBITDA
$23.66B
EBITDA Margin
27.2%
Return on Equity (ROE)
30.29%
Return on Assets (ROA)
10.18%
Total Assets (FY2025)
$125.23B
Total Equity (FY2025)
$52.01B
Net Debt
$24.95B
Debt to Equity
0.629
Current Ratio
0.677
Goodwill & Intangibles
$63.6B
Operating Cash Flow (FY2025)
$17.82B
Free Cash Flow (TTM)
$12.84B
CapEx (FY2025)
$3.77B
Dividends Paid (FY2025)
$9.87B
Share Repurchases (FY2025)
$6.50B
52-Week High
$167.25
52-Week Low
$137.62
50-Day MA
$147.33
200-Day MA
$148.05
Total Shareholder Yield
~6.0%
Strengths
Concerns
Procter & Gamble is a quintessential blue-chip consumer staples investment combining defensive characteristics (0.38 beta) with high-quality profitability (30% ROE, 18% net margins). Revenue grew 3.3% TTM to $87.03B with gross margin expansion to 50.7%. The company returned $16.4B to shareholders in FY2025 through dividends and buybacks. Main risk is premium valuation at 19.6x forward earnings and PEG of 5.57x. Recommended action is HOLD for existing shareholders; BUY on weakness below $148 for long-term income-focused investors.